Medeze Group PCL (MEDEZE)

Currency in THB
7.35
-0.05(-0.68%)
Closed·
MEDEZE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MEDEZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.307.50
52 wk Range
5.7513.80
Key Statistics
Bid/Ask
7.35 / 7.40
Prev. Close
7.4
Open
7.45
Day's Range
7.3-7.5
52 wk Range
5.75-13.8
Volume
1.6M
Average Volume (3m)
1.93M
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDEZE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.20
Upside
+52.38%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Medeze Group PCL Company Profile

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition, the company sells dietary supplements, cosmetics, and dermo cosmetics. The company was founded in 2010 and is based in Nakhon Pathom, Thailand.

Compare MEDEZE to Peers and Sector

Metrics to compare
MEDEZE
Peers
Sector
Relationship
P/E Ratio
22.1x17.2x−0.5x
PEG Ratio
6.09−0.820.00
Price/Book
2.6x1.8x2.6x
Price / LTM Sales
8.7x1.5x3.2x
Upside (Analyst Target)
52.4%32.4%41.7%
Fair Value Upside
Unlock27.6%6.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.20
(+52.38% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.38%
Dividend Yield
2.18%
Industry Median 3.45%
Annualised payout
0.16
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.07 / --
Revenue / Forecast
205.00M / --
EPS Revisions
Last 90 days

MEDEZE Income Statement

People Also Watch

21.00
BDMS
-0.47%
8.30
KAMART
-0.60%
159.00
KBANK
-0.93%
29.25
MEGA
+1.74%
13.10
MASTER
-1.50%

FAQ

What Stock Exchange Does Medeze PCL Trade On?

Medeze PCL is listed and trades on the Thailand Stock Exchange stock exchange.

What Is the Stock Symbol for Medeze PCL?

The stock symbol for Medeze PCL is "MEDEZE."

What Is the Medeze PCL Market Cap?

As of today, Medeze PCL market cap is 7.85B.

What Is Medeze PCL's Earnings Per Share (TTM)?

The Medeze PCL EPS (TTM) is 0.38.

When Is the Next Medeze PCL Earnings Date?

Medeze PCL will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is MEDEZE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Medeze PCL Stock Split?

Medeze PCL has split 0 times.

How Many Employees Does Medeze PCL Have?

Medeze PCL has 200 employees.

What is the current trading status of Medeze PCL (MEDEZE)?

As of 26 Jul 2025, Medeze PCL (MEDEZE) is trading at a price of 7.35, with a previous close of 7.40. The stock has fluctuated within a day range of 7.30 to 7.50, while its 52-week range spans from 5.75 to 13.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.